Phoenix Local Business
Thursday, June 9, 2016
FDA Panel Favors New C. Diff. Biologic
(MedPage Today) -- Panel votes 10-5 that bezlotoxumab showed evidence of safety, effectiveness
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment